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ABSTRACT — The extent of ageing in the musculoskeletal 
system during the life course affects the quality and length of 
life. Loss of bone, degraded articular cartilage, and degenerate, 
narrowed intervertebral discs are primary features of an ageing 
skeleton, and together they contribute to pain and loss of mobility. 
This review covers the cellular constituents that make up some 
key components of the musculoskeletal system and summarizes 
discussion from the 2015 Aarhus Regenerative Orthopaedic Sym-
posium (AROS) (Regeneration in the Ageing Population) about 
how each particular cell type alters within the ageing skeletal 
microenvironment. 
■
In the ageing skeleton, bone volume and mass declines in both 
sexes and in people of all ethnic backgrounds, often manifest-
ing as osteoporosis and an increased risk of fracture. Loss of 
cartilage thickness in synovial joints with age contributes to 
osteoarthritis while decreasing structural integrity within the 
intervertebral discs (IVDs) leads to loss of disc height, and 
collapse and compression within the spine. 
In these individual tissue compartments, there is a delicate 
cellular balance where the differentiation and activity of spe-
cifi c cell types are matched to the local requirements. Whereas 
some skeletal elements rely on individual cell types acting 
remotely and in isolation (e.g. osteocytes, chondrocytes), 
others depend on a diverse population of cells, derived from 
widely different stem cell lineages, to work together to reach 
the common goal of maintaining skeletal integrity throughout 
life. 
Bone
Bone strength and volume is preserved as we age by the con-
stant, balanced remodeling of the skeleton—a balance that is 
not maintained in the ageing bone microenvironment.
Stem cells and ageing bone
Bone-forming osteoblasts derive from mesenchymal stem 
cells (MSCs). MSCs can be stimulated to form a range of 
cell types including chondrocytes, myocytes, adipocytes, and 
fi broblasts depending on the local stimuli (Ferrari et al. 1998, 
Awad et al. 1999, Pittenger et al. 1999). Consequently, altera-
tions in the number and activity of MSCs have the potential to 
affect a range of musculoskeletal tissues by altering progeni-
tor cell numbers, not least osteoblasts. MSCs isolated from 
aged donors showed a reduced capacity to expand in vitro and 
appeared fl at and widespread compared to rapidly proliferat-
ing, spindle-shaped cells from younger donors (Colter et al. 
2001, Baxter et al. 2004). Increased granulation within the 
cytoplasm was also observed (Bonab et al. 2006), suggesting 
an accumulation of waste protein material that typically results 
from impaired autophagy, another age-related mechanism. 
Aged MSCs also show increased levels of cellular senes-
cence, a state of irreversible growth arrest, where increased 
expression of p53, p21, and senescence-associated β-galac-
tosidase is seen in MSC cultures from old donors compared 
to young donors (Stenderup et al. 2003, Stolzing et al. 2008). 
A shift in differentiation potential is also clear, as aged MSCs 
favor adipocyte formation at the expense of osteoblast forma-
tion, leading to increased fat accumulation within the bone 
marrow (a feature common in ageing bone) and reduced bone 
formation (Moore and Dawson 1990, Sethe et al. 2006). This 
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is probably driven by an age-related downregulation of osteo-
genic genes including Runx2 and osteocalcin (D’Ippolito et 
al. 1999, Lazarenko et al. 2007) coupled with an upregulation 
of adipocyte-specifi c genes such as PPAR-γ and the adipocyte 
fatty acid-binding protein (aP2) (Moerman et al. 2004, Jiang 
et al. 2008). 
Sirtuins
The infl uence of ageing and longevity-related mechanisms on 
such crucial regulators of transcription within skeletal cells 
may also contribute strongly to the age-related change we 
see in normal cell biology. The sirtuin gene family is closely 
linked to the regulation of lifespan (Kaeberlein et al. 1999). 
Overexpression of the principal mammalian homolog SirT1 in 
early mesenchymal progenitors increased Runx2 and Osterix 
expression, while inhibition of SirT1 decreased Runx2 expres-
sion (Cohen-Kfi r et al. 2011) and increased the activity of pro-
adipocyte factor PPAR-γ (Picard et al. 2004). Importantly, 
SirT1 declines with ageing in a variety of tissues (including 
musculoskeletal sites) and may be a common mediator of 
both ageing and the onset of age-related disorders. Geneti-
cally modifi ed mice lacking SirT1 had a bone loss phenotype 
similar to that seen in human age-related bone loss (Cohen-
Kfi r et al. 2011), while tissue-specifi c deletion of SirT1 in 
either osteoblast- or osteoclast-lineage cells decreased bone 
volume either through impaired bone formation or exces-
sive bone resorption (Edwards et al. 2013, Iyer et al. 2014). 
The deacetylase activity of SirT1 offers many mechanisms 
through which SirT1 may mediate bone biology, including 
inhibition of NFkB (Yeung et al. 2004, Edwards et al. 2013) 
and PPAR-γ (Picard et al. 2004) transcription factors. Loss of 
SirT1 with increasing age may therefore enhance infl amma-
tory responses, osteoclast formation, and adipocyte formation, 
common physiological features of ageing and crucial systems 
in the maintenance of musculoskeletal health. SirT1 also sup-
presses sclerostin (Cohen-Kfi r et al. 2011), a potent inhibitor 
of the anabolic Wnt signaling pathway in bone. As SirT1 levels 
decline with age, sclerostin is released from inhibition to sup-
press bone formation. In support of this mechanism, circulat-
ing sclerostin levels are increased in elderly humans compared 
to young individuals (Modder et al. 2011), effectively acting 
as a brake on Wnt signaling in the ageing skeleton; it is also 
thought to be released by osteoclasts in aged mice—only to 
block coupled bone formation (Ota et al. 2013).
Wnt signaling activates β-catenin to control osteoblast dif-
ferentiation and function. Signaling through LRP5/6 by Wnts 
prevents degradation of β-catenin, allowing its concentration 
to rise in the cytoplasm. After translocation to the nucleus, its 
association with the TCF/LEF transcription co-factors stimu-
lates osteoblastogenesis and reduces osteoclastogenesis by 
activating genes for factors such as alkaline phosphatase and 
osteoprotegerin, to increase bone mass and reduce resorption 
and fat cell accumulation (Kolpakova and Olsen 2005, Rosen 
and MacDougald 2006).
Forkhead proteins
In a similar manner to sclerostin, the Forkhead transcription 
factor FoxO can also reduce Wnt signaling by sequestering of 
β-catenin. FoxO is implicated in ageing, where C. elegans and 
Drosophila studies have suggested a benefi cial effect on lon-
gevity. Activation of FoxO proteins as a cellular response to 
oxidative stress appears to underscore many of their protective 
effects, and elevated levels of reactive oxygen species (ROS) 
such as superoxide anions are common in the ageing cellular 
environment. Indeed, posttranslational modifi cations induced 
by the presence of ROS are potent stimuli for FoxO1, -3, and 
-4 activity in mammals (Calnan and Brunet 2008). In opposi-
tion to the canonical Wnt pathway described above, activation 
of FoxO proteins under conditions of oxidative stress creates a 
competitive intracellular environment for the binding of avail-
able β-catenin, and where reduced numbers of osteoblasts are 
formed at the expense of cell survival mechanisms (Manolagas 
and Almeida 2007, Iyer et al. 2013). This may be suppressed in 
part by the action of SirT1 to deacetylate and inactivate FoxO 
(Iyer et al. 2014). However, the signifi cance of FoxO proteins 
in skeletal homeostasis is highlighted by osteoblast-specifi c 
deletion of FoxO1, -3, and -4 where increased oxidative stress 
and osteoblast apoptosis are coupled to reduced osteoblast 
number, bone formation rate, and cortical and cancellous bone 
volume (Ambrogini et al. 2010), demonstrating clearly how 
changes in environmental stimuli—such as those experienced 
during ageing—alter normal biological processes.
mTOR signaling
Inhibition of the serine/threonine protein kinase mTOR is 
another ageing-associated mechanism that extends lifespan 
in model organisms and mammals (Vellai et al. 2003, Kapahi 
et al. 2004, Kaeberlein et al. 2005). mTOR expression infl u-
ences cell growth, motility, survival, protein synthesis, and 
recycling. As such, changes in the regulation of this crucial 
protein have the potential to dramatically affect bone cells. 
In vitro inhibition of mTOR with rapamycin activates osteo-
genic genes in MSCs (e.g. Runx2, Osterix) while suppress-
ing genes linked to stem-ness (e.g. Oct3/4, nanog). In mature 
osteoblasts, rapamycin promoted increased alkaline phospha-
tase production and mineralization (Lee et al. 2010), while 
disrupting the OPG/RANKL ratio to reduce osteoclastogen-
esis in bone marrow cells (Mogi and Kondo 2009). This fi nd-
ing is recapitulated in vivo, where use of the mTOR inhibitor 
everolimus protects against ovariectomy-induced bone loss 
by reducing osteoclast formation and release of the matrix-
degrading enzyme cathepsin K (Kneissel et al. 2004).
Ageing-related hormonal effects
In the ageing skeleton, the effects of reduced osteoblast activ-
ity are compounded by increased osteoclast formation and 
function (Figure 1). The resulting excessive bone destruc-
tion reduces skeletal volume and strength and predisposes 
to increased risk of fracture. Alongside changes in lifespan-
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regulating mechanisms, age-related changes in sex hormones 
also affect normal skeletal biology. In women, the decline in 
estrogen levels following menopause leads to a dramatic loss 
of bone in both cortical and trabecular compartments (Riggs 
et al. 1998, Manolagas 2000). This results from an elevated 
bone turnover rate where osteoclasts are released from estro-
gen inhibition to increase overall bone resorption. The cou-
pled relationship between osteoclastic resorption and bone 
formation triggers an increase in osteoblasts (Han et al.1997); 
the increase in bone formation rate is, however, insuffi cient to 
match the excessive destruction by overstimulated osteoclasts. 
In men, low levels of androgens also cause increased bone 
remodeling and net bone loss (Daniell 1997, Katznelson et al. 
1996), attributed in part to reduced levels of estrogen, which 
is derived from aromatization of testosterone (Falahati-Nini 
et al. 2000).
Cellular responses to the hormone insulin-like growth 
factor 1 (IGF1) are also altered with age, where proliferative 
osteoblast numbers are reduced with increasing age in both 
basal and IGF1-stimulated settings. In addition, increased age 
reduces the ability of IGF1 to form osteogenic progenitor cells 
(Cao et al. 2007). Pro-proliferative and anti-apoptotic effec-
tors normally stimulated by IGF1 are also reduced in aged 
cells as compared to younger cells. Overall, this suggests that 
ageing leads to a reduction in cellular sensitivity to IGF1 sig-
naling, thus contributing to bone loss.
The coupled, interdependent, local co-regulation of bone 
cells is also dysregulated in old skeletal microenvironments as 
compared to young ones. Stromal or osteoblastic cells co-cul-
tured with osteoclast progenitors typically encourage osteo-
clastogenesis. However, osteoclastogenesis is dramatically 
increased when old stromal or osteoblastic cells are cultured 
(compared to cells from young donors), due to the increased 
expression with age of pro-osteoclastogenic factors such as 
RANKL and M-CSF (Cao et al. 2005). Interestingly, aged 
bone itself also stimulates higher levels of osteoclast forma-
tion and resorption (Henriksen et al. 2007), suggesting that the 
age-related change in matrix proteins within bone also affects 
the ageing cellular environment. 
Furthermore, the ability of cells from many lineages to 
sense and respond to mechanical changes is altered with age, 
adversely affecting their capacity to resist tissue damage (Wu 
et al. 2011). Embedded within bone, the solitary isolated 
osteocyte is the principal mechanosensor, relaying signals to 
the surface of bone to trigger changes in bone and possibly 
also muscle (Bonewald 2015). Increased osteocyte apoptosis 
occurs with age, reducing the skeleton’s capacity to sense and 
respond to mechanical forces. Osteocytes respond to changes 
in loading in various ways, such as through alterations in cal-
cium fl ux (Huang and Ogawa 2010) or interferon-γ concentra-
tions, where older cells fail to transduce mechanical forces—
such as fl uid fl ow—into changes in cell function (Donahue et 
al. 2001).
Articular cartilage 
Articular cartilage shows distinct regional variations in the 
biochemistry and organization of the matrix, and of the cells 
within it. Similarly, the apparent simplicity of the avascular, 
aneural articular cartilage being populated with a single cell 
type—chondrocytes—is deceiving, as chondrocytes from dif-
ferent regions or zones of the cartilage have different capa-
bilities (Aydelotte and Kuettner 1988), but how much of that 
is inherent and how much is dictated by the environment of 
the cells is unknown (Hayes et al. 2007). Those cells from 
the upper superfi cial zone were smaller and had higher activi-
ties of lysosomal enzymes, but synthesized less proteogly-
cans (PGs) and less keratan sulfate (KS) glycosaminoglycans 
(GAGs) than the larger cells in the deep zone. These in turn 
had more rough endoplasmic reticulum, had more glycogen 
and lipid deposits, proliferated faster in culture, and synthe-
sized more GAGs (Aydelotte and Kuettner 1988). In addition 
to these zonal subpopulations, a further population of progeni-
tor cells has been identifi ed in cartilage, as in most other tis-
sues (Dowthwaite et al. 2004, Candela et al. 2014). These cells 
may normally be quiescent but have the ability to respond to 
particular mechanical or biochemical stimuli (Figure 2).
During ageing, articular cartilage undergoes changes to its 
molecular structure with some, but not all, changes resembling 
those seen in degeneration associated with osteoarthritis (OA). 
The most notable quantitative changes are a decrease in water 
content and fragmentation of the core protein of the main PG, 
aggrecan, and also of the chondroitin sulfate (CS) GAGs, but 
there is an increase in KS content (Hardingham and Bayliss 
1990). Hyaluronan, in contrast, increases 4-fold from birth 
to 90 years of age. In addition, there is increased proteolytic 
fragmentation of the collagen molecules by collagenase and 
cathepsin K with increasing age, resulting in reduced tensile 
strength (Dejica et al. 2012). 
There are also many more subtle changes in the biochem-
istry of cartilage with increasing age, including altered sulfa-
tion patterns on the GAG chains, a switch in types of collagen 
Figure 1. Bone remodeling. Bone is continually remodeled throughout 
life. The coordinated activity of bone-resorbing osteoclasts and bone-
forming osteoblasts ensures that adequate skeletal mass is main-
tained. As we age, the delicate balance between bone removal and 
bone production is disrupted, resulting in an overall loss of bone.
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produced (more type-I:II and increased type-IX:II), as well as 
an alteration in crosslinking between the collagen molecules. 
“Mature” hydroxypyridinium crosslinks, which are 5- to 
10-fold higher in cartilage than in bone, increase from birth 
to ~15 years of age in cartilage and then stay consistent to 
at least 80 years of age. In contrast, the reducible aldimine 
crosslinks, which are present during the development of car-
tilage, are virtually absent by the age of 15 years. In addi-
tion to these, there are of course a myriad of other age-related 
changes to other extracellular matrix components (ECM), 
including the small leucine-rich proteoglycans (SLRPs), carti-
lage oligomeric matrix protein (COMP), and the appropriately 
named advanced glycation end-products (AGEs) (described in 
reviews such as that by Heinegard and Saxne (1991)).
Ageing chondrocytes
Of the various signatures of cellular ageing described (Lopez-
Otin et al. 2013), cellular senescence has been shown to 
increase in human chondrocytes from the age of 1 to 87 years, 
with a concomitant decrease in telomere erosion and reduced 
mitochondria (Martin and Buckwalter 2001). This chondro-
cyte senescence has been linked to an age-related decrease in 
the chondrocyte’s responsiveness to anabolic growth factors 
such as IGF (Loeser et al. 2000) and to synthesis of smaller 
matrix molecules (e.g. aggrecan and link protein), with oxi-
dative damage causing mitochondrial degeneration (Martin 
and Buckwalter 2002). Little is known about oxygen ten-
sions within the avascular environment of articular cartilage. 
Reported measurements of partial pressure of oxygen in vitro 
are 1% to 2.5% in the mid-zone of cartilage plugs (Silver 
1975). Chondrocytes, although suited to a low oxygen envi-
ronment, do consume oxygen, albeit at low rates when com-
pared to other cell types (Zhou et al. 2004). However, how 
chondrocytes use oxygen is unclear. They contain a very low 
number of mitochondria (Stockwell 1991) compared to most 
other cell types, and derive most of their energy from an oxy-
gen-independent process via the Embden-Meyerhof-Parnas 
pathway of glycolysis (Lee and Urban 1997, Zhou et al. 2004). 
Certainly, oxygen is required for proteoglycan synthesis, 
which is thought to decrease signifi cantly with decreasing 
oxygen tension below 5% (Lee and Urban 1997, Grimshaw 
and Mason 2000). Although chondrocytes have been shown 
to survive for several days without oxygen (Grimshaw and 
Mason 2000, Zhou et al. 2004), it has been suggested that 
oxygen tensions as low as ~1% are unlikely to exist in vivo, 
except under abnormal conditions. These abnormal conditions 
may relate to different disease pathologies, with the oxygen 
tension in synovial fl uid varying depending on the pathology 
of the joint. For example, a pO2 of 0–6% has been reported 
in patients with rheumatoid arthritis, 3–9% in osteoarthritis, 
6–11% in patients with traumatic exudates (Lund-Olesen 
1970), and ~1% in degenerate intervertebral disc (Rajpurohit 
et al. 2002) (discussed below). The level of oxygen in normal 
rabbit cartilage has been shown to be 3–10% (Ferrell and 
Najafi pour 1992). The supply of oxygen, as well as of other 
nutrients, reaches the cartilage not only from the synovial fl uid 
(which is in turn supplied by the vasculature of the joint cap-
sule and the synovium) but also from the subchondral bone 
(Houard et al. 2013). Age-related changes in the subchondral 
bone, which often undergoes signifi cant remodeling (Loeser 
2010), would probably affect the oxygen tension in the joint, 
as would increasing calcifi cation of the cartilage itself, which 
has also been associated with advancing age.
Like other tissues including bone, articular cartilage appears 
to be susceptible to damage caused by oxidative stress. Chon-
drocytes can produce both ROS such as superoxide anions 
and nitric oxide (NO), which is known to be upregulated by 
IL-1 and to react with tyrosine residues to form 3-nitrotyro-
sine (Loeser et al. 2002). This is found at increased levels both 
in aged and osteoarthritic articular cartilage in humans, and 
has been shown to cause damage in ageing-associated degen-
eration in other tissues such as brain and muscle. Since many 
cell signaling proteins use tyrosine phosphorylation for activa-
tion, the formation of nitrotyrosine residues will interfere with 
this, and may be responsible for the reduction in chondrocyte 
response to IGF, since NO can lead to a reduction in tyrosine 
phosphorylation of the IGF-1 receptor. van der Kraan et al. 
(2012) have shown that there is a shift in SMAD 1/5/8 sig-
naling with age. Since these SMAD pathways are involved in 
TGFβ signaling (via the activin receptor-like kinase (ALK) 
1 and 5), the increased ratio of ALK 1 to ALK 5 found with 
age results in a correlated increase in MMP-13 expression, 
and possibly in the autolytic chondrocyte phenotype which is 
found in senescent chondrocytes. Another cytokine that has 
been shown to have elevated expression with increased age is 
IL-7 (Rubenhagen et al. 2012). The AGEs that accumulate in 
chondrocytes from older individuals appear to activate janus 
Figure 2. Zones and constituents of articular cartilage. A schematic 
representation of the different matrix components and their organiza-
tion throughout articular cartilage.
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kinase 2 and 3 signal transducer and STAT 3 phosphorylation, 
and lead to increased MMP13 and ADAMTS-4 and -5 expres-
sion and activity (Huang et al. 2011). 
Mutations in the mitochondrial DNA of chondrocytes 
(which may result from exposure to cytokines or ROS) may 
also contribute to the age-related changes in articular carti-
lage (Blanco et al. 2011). They can affect several pathways, 
including defective chondrocyte biosynthesis and increased 
apoptosis. Certainly, accumulation of ROS and AGEs can 
promote the senescent phenotype in chondrocytes (Leong 
and Sun 2011), conferring not only reduced anabolic activ-
ity and synthesis of proinfl ammatory cytokines and degrada-
tive enzymes, but also triggering an impaired response to the 
mechanical and infl ammatory insults to the cartilage. This 
may be the reason for OA developing much more quickly in 
the destabilized medial meniscus (DMM) model of mechani-
cal instability in 12-month-old mice than in 12-week-old 
mice (Loeser et al. 2012). There is differential expression of 
immune response genes in the old and young DMM mice, 
which may be a key factor in the association between the 
development of OA with increasing age, where an increas-
ing degree of low-grade, chronic infl ammation occurs (or 
“infl ammaging” (Franceschi et al. 2007)). Greene and Loeser 
(2015) suggested that this process is key to the increased like-
lihood of developing OA with advancing age, with overall 
adiposity playing an important part, where greater amounts 
of adipose tissue in older (or obese) individuals promote sys-
temic infl ammation and elevated levels of IL-6 and TNFα 
(Greene and Loeser 2015).  
The genes controlling all the anabolic, catabolic, and sig-
naling pathways can of course be affected by epigenetic 
infl uences, which add another complete level of complexity, 
and effector mechanisms. As described for bone cells above, 
SirT1 promotes chondrocyte survival and matrix gene expres-
sion also, and can be cleaved and inactivated by TNFα (Li 
et al. 2013). Similarly, some miRNAs have been identifi ed 
that become upregulated with age (miR199a, miR193p, and 
miR193b) and which appear to be anti-anabolic, whereas 
miR320c expression is downregulated (reviewed by Li and 
colleagues (2013)).
If cell therapy is being used to repair or regenerate diseased 
joints, such as in OA, it is likely to be occurring in an older 
individual. If autologous therapy is being undertaken, the phe-
notype of the cells (in terms of senescence) to be implanted 
could affect their ability to effect repair. At our center (RJAH 
Orthopaedic Hospital NHS Trust), we have, however, seen no 
reduction in terms of clinical benefi t from autologous chon-
drocyte implantation to date, which relates to the age of the 
patient (unpublished data).  
Intervertebral discs
IVDs are composed of a central highly hydrated tissue named 
the nucleus pulposus (NP) surrounded by a fi brous ring, the 
annulus fi brosus (AF). Both tissues are enclosed between 
the vertebral endplates. In most mammals, the fi rst signs of 
IVD degeneration start early in life and mainly affect the NP 
(Boos et al. 2002) (Figure 3). During IVD growth, 2 cell types 
populate the NP: the nucleopulpocytes (NPCytes) and the 
notochordal cells (NTCs) (Hunter et al. 2004, Colombier et 
al. 2014). Nucleopulpocytes are the effector cells of the NP, 
which are responsible for the synthesis of extracellular matrix 
(ECM) components, while NTCs are considered to be the NP 
progenitors, maintaining homeostasis (Aguiar et al. 1999, 
Erwin et al. 2006, 2011, McCann et al. 2011). The progressive 
loss of NTCs during skeletal maturation may be one of the 
fi rst events leading to the initiation of the degenerative cascade 
observed in ageing IVD. Some elements of the pathophysiol-
ogy of the NP, the AF, and the cartilage endplates (CEPs) will 
be given below.
Pathophysiology of the nucleus pulposus
The NP contains mainly NTCs and NPCytes embedded in a 
matrix that, like cartilage (described above), is rich in type-II 
collagen (COL2) and PGs (Clouet et al. 2009, Risbud et al. 
2015). Aggrecan is the main PG found in the NP, containing 
~30 chains of sulfated GAGs, which contribute to the negative 
charge that gives the hyper-hydrated state of the NP. These 
aggrecan molecules are embedded in type-II collagen fi bers 
Figure 3. The human intervertebral disc. A. Schematic view of the human lumbar spine,  composed of vertebral bodies (VB) and intervertebral 
discs (IVD). B. Histological appearance of young and old human intervertebral discs stained with Alcian blue.
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to form a specifi c network that allows the NP to be elastic 
and deform under stress. A third cell type has recently been 
described, displaying progenitor properties similar to those of 
MSCs (Sakai et al. 2012). The expression of the notochordal 
markers brachyury and cytokeratin 8 by these progenitor cells 
has not been thoroughly described, however, making their 
origin unclear. NP cells are highly specialized, having adapted 
to survive in a more severe hypoxic environment than articu-
lar cartilage (1% O2). For this reason, the hypoxia-inducible 
transcription factors 1 and 2 (HIF-1 and HIF-2), which are key 
cellular regulators of the hypoxic response, were found to be 
constitutively active in NP cells (Rajpurohit et al. 2002). Inter-
estingly, the promoter of the aggrecan gene has been found to 
be regulated by HIF-1 (Agrawal et al. 2007). The constitutive 
activity of HIF-1 might therefore be partly responsible for the 
large production of aggrecan by NP-resident cells. 
Numerous studies have suggested the existence of a 
molecular dialog between NTCs and NPCytes responsible 
for the maturation of the NP, the synthesis of functional 
ECM, and the survival of NPCytes as we age (Nerlich et al. 
2005, Erwin et al. 2006, Dahia et al. 2009, 2012, Erwin et 
al. 2011). NPCytes secrete TGF-β, which positively regulates 
the expression and secretion of the connective tissue growth 
factor (CTGF/CCN2) by NTC through a Smad-binding ele-
ment in the CTGF/CCN2 promoter (Leask et al. 2001, Chen 
et al. 2002, Tran et al. 2010). The secretion of CTGF/CCN2 in 
turn ensures the proliferation of NPCytes and the synthesis of 
aggrecan (Erwin et al. 2006). In addition, some yet uncharac-
terized factors secreted by NTCs have the ability to inhibit the 
activation of the apoptotic caspases 3 and 9, thereby favoring 
the expression of aggrecan (Erwin et al. 2011). Finally, similar 
to the HIF-1 regulation in NP cells, it has been reported that 
increased oxygen tension negatively affects the expression of 
CTGF/CCN2 by NTCs (Tran et al. 2013a). Thus, this mecha-
nism not only controls the hypoxic response in NP cells, but 
also the secretion of CTGF/CCN2—which controls PG pro-
duction. 
Taken together, these results highlight the fundamental role 
of NTCs in the survival and activity of NPCytes, which subse-
quently maintain NP homeostasis. The gradual disappearance 
of NTCs during skeletal maturation and ageing is therefore 
likely to disturb the molecular dialog between NP cells, and is 
the leading event in initiating degeneration of the NP.
Degenerative events 
The complete disappearance of NTCs at skeletal maturity in 
humans is concomitant with the activation of ageing-related 
cellular responses including apoptosis, senescence, and 
autophagy. NP cell apoptosis could be initiated through sev-
eral caspase-dependent pathways (Thornberry and Lazebnik 
1998). This caspase activation during degeneration results 
either from the death receptor-mediated extrinsic pathway 
(Bachmeier et al. 2007) or the intrinsic pathway, which is 
linked to mitochondrial activity, especially during the most 
advanced stages of degeneration (Rannou et al. 2004, Wang et 
al. 2014). Resident NP cells have limited spontaneous repair 
properties. However, autophagy and senescence mechanisms 
are activated in NP cells during degeneration to protect from 
cell death.
Autophagy is a process that allows cells to generate their 
own energy under conditions of high stress, such as prolonged 
nutrient defi ciency (Rubinsztein et al. 2011). During degener-
ation, both the number of autophagosomes and the autophagic 
fl ow were found to increase gradually (Ye et al. 2011). This 
upregulation of autophagy-associated events strongly sug-
gests that NP cells have the potential to compensate for nutri-
ent deprivation by generating their own energy when exposed 
to intense stress. The second mechanism of cell protection 
observed in NP degeneration relates to senescence. This cell 
mechanism involves the entry of cells into the non-prolif-
erative G0 phase of the cell cycle. Upon entry into the G0 
phase, cells no longer respond to environmental cues, which 
can allow evasion of programmed death (Herbig et al. 2006). 
Interestingly, it has been found that NP cells experience repli-
cative senescence during ageing (Kim et al. 2009).
The cellular modifi cations observed in the NP are accompa-
nied by ECM remodeling. Surprisingly, CTGF/CCN2, which 
is involved in the establishment of the NP-specifi c ECM 
during growth, has also been found to promote degeneration 
(Tran et al. 2010). This dual effect may be mainly explained 
by the loss of regulation of CTGF/CCN2 expression. Indeed, 
an abnormal accumulation of CTGF/CCN2 is observed in the 
NP while NTCs disappear during ageing. This growth factor 
presents several domains that interact with a large set of mol-
ecules including PGs, which may account for its accumulation 
throughout life (Tran et al. 2013a and b). This accumulation 
may also be explained by the increase in TGF-β in the NP, 
which positively regulates the expression of CTGF/CCN2 
(Lee et al. 2009). This increase in TGF-β and CTGF/CCN2 
activates a fi brotic repair response of NP cells, characterized 
by the deposition of type-I collagen fi bers. 
A disequilibrium between the disappearance of NTC-
secreted protective factors and the increase in factors asso-
ciated with senescent cells (senescence-associated secretory 
phenotype) results in an increase in the expression of matrix 
metalloproteinases (including MMP3 and MMP7) and a dis-
integrin and metalloproteinase with thrombospondin repeats 
(ADAMTS) (Roberts et al. 2000, Freund et al. 2010). These 
enzymes are capable of degrading both collagen and PGs, 
leading to dehydration and progressive disorganization of 
ECM. Under these conditions, it has been observed that the 
ECM takes on a grainy appearance and shows cracks and 
tears. In addition, an increase in the secretion of interleukins 
(IL-6 and IL-8), vascular endothelial growth factor (VEGF), 
and nerve growth factor (NGF) has been reported following 
the increased ADAMTS and MMP expression seen in ageing, 
promoting vessel and neurite ingrowth in painful discs during 
degeneration (Burke et al. 2002, Ohba et al. 2009, Cornejo et 
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al. 2015, Purmessur et al. 2015). The progressive change in 
the ECM of the NP ultimately leads to the loss of the biome-
chanical functions of IVDs that is associated with increasing 
age. 
Pathophysiology of the annulus fi brosus
The AF can be divided into 2 distinct areas: the outer AF and 
the inner AF. The inner AF, which is also known as the transi-
tion zone, contains chondrogenic cells and a poorly organized 
ECM that is composed of type-II collagen, PGs, and water. In 
contrast, the outer AF is populated by fi broblasts and a highly 
organized ECM rich in type-I collagen, and type-II collagen 
and PGs are much less obvious in this region (Eyre and Muir 
1976). AF cells have membranous mechanoreceptors and are 
very sensitive to mechanical stress (Dimitroulias et al. 2010). 
The secretion of sonic hedgehog (SHH) by NTCs in the NP is 
involved not only in the maintenance of the AF cell identity 
but also in the control of their secretory activity (type-I and 
type-II collagen) (Dahia et al. 2012). The ECM of the AF is 
organized into 15–25 concentric lamellae oriented at 65° rela-
tive to the vertical plane (Hayes et al. 2011). These lamellae 
are interconnected by PG aggregates, elastin and lubricin, and 
also type-VI collagen fi bers (Melrose et al. 2008, Shine et al. 
2009). Moreover, the outer AF has a higher resistance to ten-
sion than the inner AF. Collectively, the fi brous structure of the 
AF gives important mechanical properties that limit protru-
sion of the NP.
The interruption in SHH secretion by NTC during degen-
eration leads to a differentiation of AF cells into hypertrophic 
cells that are unable to secrete type-II collagen (Kondo et al. 
2011, Haschtmann et al. 2012). This differentiation leads to 
modifi cation of the tensile strength of the AF, and thus to a 
modifi cation of cell response to overload. In this context, it 
has been described that AF cells undergo massive apoptotic 
cell death in response to overload (Rannou et al. 2004). Degra-
dation of matrix components is later initiated in the AF, result-
ing in destabilization of its structure. During this process, the 
collagen fi bers become thinner and more irregular, eventually 
leading to cracks.
Pathophysiology of the cartilage endplates
CEPs are composed of a thin layer of hyaline cartilage adja-
cent to the vertebral bony endplate. Like articular cartilage, 
these CEPs are composed of chondrocytes that synthesize a 
COL2- and PG-enriched ECM, with a ratio of PG to type-
II collagen of approximately 2:1. These PGs effi ciently allow 
hydration of the ECM, with a water content of around 50–60% 
(Roberts et al. 1989). The vertebral endplates are the site of 
a microscopic network of blood vessels that are responsible 
for nutritional intake during development and growth of IVDs 
(Taylor 1975, Benneker et al. 2005, Hee et al. 2011). Metabo-
lites diffuse through the pores present in the CEP, based on 
their size and charge. Positive ions (e.g. sodium, calcium) or 
neutral molecules, such as glucose and oxygen, diffuse most 
readily (Grunhagen et al. 2006). Cartilage endplates also 
undergo degenerative events with increasing age, exacerbat-
ing NP degeneration. Indeed, the disappearance of NTCs in 
the NP is concomitant with the commitment of endplate chon-
drocytes to a hypertrophic phenotype. The activity of alka-
line phosphatase increases and chondrocytes start to secrete 
type-X collagen, which ultimately leads to calcifi cation of the 
ECM (Aigner et al. 1998, Sahlman et al. 2001, Paietta et al. 
2013). Endplates become impermeable, which not only blocks 
the diffusion of nutrients but also the removal of metabolites 
in the NP. These events dramatically alter IVD homeostasis, 
mainly by inducing acidifi cation and restricting the supply of 
oxygen and nutrients. 
Musculoskeletal vasculature
For decades, the vasculature of the musculoskeletal system 
has been perceived merely as a means of supplying oxygen 
and nutrients, and for disposal of waste products. However, 
recent discoveries suggest a close crosstalk between the vas-
cular and osteogenic niches and a bilateral infl uence of both. 
As in other tissues of the body, ageing-dependent changes 
occur within the vasculature also. Arteries become increas-
ingly stiff and hard, due to changes in the vessel wall, where 
calcifi cation and glycosylation are chiefl y responsible. These 
processes take place in the inner 2 vessel layers, namely the 
intima and media. The outer layer, the adventitia, is also 
affected by ageing, with an increase in collagen fi bers and 
fi broblasts (Kovacic et al. 2011). An intriguing “calcifi cation 
paradox” has been suggested, where increased calcifi cation of 
the vasculature occurs while the bone becomes less calcifi ed 
with increasing age (Persy and D’Haese 2009). Defi ciency of 
the protein osteoprotegerin in mice results in a severe decrease 
in bone density due to elevated osteoclastogenesis, but—inter-
estingly—this is accompanied by elevated vascular calcifi ca-
tion (Bucay et al. 1998), suggesting a link between the 2 pro-
cesses. Also, mutation of the klotho gene leads to a condition 
resembling human ageing and involving vessel calcifi cation 
and bone decalcifi cation in the mouse (Kuro-o et al. 1997). 
Pericytes are ubiquitously distributed around the endo-
thelium throughout the human body. These cells are closely 
related to mesenchymal stromal cells and can dedifferenti-
ate into osteoprogenitor cells with osteoblastic capabilities 
(Bostrom et al. 1993, Kovacic et al. 2011). Furthermore, 
phenotypic switching of endothelial cells to become osteo-
blasts and chondrocytes has been proposed (Medici et al. 
2010). Recent discoveries in mice suggest a close relationship 
between a specifi c subset of endothelial cells and bone for-
mation (Kusumbe et al. 2014, Ramasamy et al. 2014, 2015). 
These cells are known as type H endothelium; they are found 
in close proximity to osteoprogenitors and promote angio-
genesis and bone formation via paracrine Dll4-Notch sig-
naling (Ramasamy et al. 2014). Interestingly, the same path-
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way inhibits angiogenesis in many other tissues (Thomas et 
al. 2013). The impaired bone remodeling and bone-forming 
capacity in aged animals seems to be related to the observed 
age-dependent decrease in type H endothelium. Intriguingly, 
bone mass could be restored by increasing levels of HIF-1α, a 
transcription factor that is pivotal in regulation of cell metabo-
lism and angiogenesis (Pugh and Ratcliffe 2003). HIF-1α was 
found to have a positive infl uence on type H endothelium, 
which upregulated Notch signaling and the release of Noggin 
downstream (Ramasamy et al. 2014). 
Noggin is known as to be an antagonist of bone-morpho-
genic proteins and acts in a paracrine fashion on the cells of 
the osteogenic niche. Nevertheless, this pathway was able 
to restore bone mass and angiogenesis in aged mice. These 
fi ndings have led some authors to name type H endothelium 
“vessels of rejuvenation” (le Noble and le Noble 2014). Type 
H endothelium expresses high levels of CD31, Pecam1, and 
endomucin and it produces signifi cant levels of Pdgfa, Pdgfb, 
Tgfb1, Tgfb3, and Fgf1 transcripts, which attract osteogenic 
cell types. In line with this, bone-forming cells were predomi-
nantly found in close proximity to type H endothelium. This 
type of endothelium appears to be a central building block for 
bone formation and homeostasis (Kusumbe et al. 2014), and 
couples angiogenesis and osteogenesis, substantiating earlier 
observations that angiogenic growth factors also increase bone 
formation (Gerber et al. 1999, Rolfi ng 2014). 
In summary, the musculoskeletal system is a dynamic envi-
ronment consisting of a variety of tissues types made up of 
several different cellular components within complex arrange-
ments of matrices. The interaction of each tissue type is essen-
tial for the adequate functioning of the skeleton as a whole, 
and as such, each region (bone, cartilage, tendon, disc, muscle 
vasculature) has the potential to signifi cantly affect the others. 
As we age, the alterations in normal biological responses lead 
to impaired tissue function, manifest in features we recognize 
as ageing (Figure 4). This is especially true in the musculo-
skeletal system, where the interdependent nature of skeletal 
components is particularly susceptible. Ongoing investigations 
identifying, characterizing, and targeting novel ageing-related 
mechanisms may serve to increase healthspan, lengthen lifes-
pan, and prevent musculoskeletal deterioration as we age. 
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